- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01208987
Improving Laboratory Follow-up by Delivering an Enhanced Medication List to Outpatient Physician Practices
March 8, 2023 updated by: Indiana University
The investigators plan to develop a process to create an Enhanced Medication List.
The INPC (Indiana Network for Patient Care) already obtains histories of medications dispensed by pharmacies from several sources: pharmacy benefit managers, RxHub, insurance companies, Medicaid, SureScripts, Wishard Health Services.
The investigators will collect all the medication data available through the INPC for an individual patient.
The investigators will enhance this medication list by including medication categories, improving the structure and appearance, displaying results of relevant laboratory tests, and adding decision support reminders.
The investigators will test the value of such an "Enhanced Medication List" by providing it to outpatient physician practices (through the DOCS4DOCS clinical messaging service, or as a fax), preferably on the day that the patient has an office visit with the physician.
The investigators will determine whether this intervention improves patient care: whether there are higher rates of recommended laboratory follow-up monitoring as a result; whether there are lower rates of harmful drug-drug interactions.
The investigators will also seek the opinions of physicians regarding the benefit of this intervention.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
5256
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Regenstrief Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- outpatient clinic patient visits
Exclusion Criteria:
- Age 18 and under
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention (with Medication History)
these patient visits generated a medication history
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Count of medications (on a patient's medication list) for which recent (within 12 months) laboratory test monitoring is missing.
Time Frame: Laboratory tests during the previous 12 months
|
The hypothesis is that the intervention (a medication history printed for the patient) would help the physician identify incomplete monitoring of laboratory test results for a subset of medications.
(For example, Potassium test levels should be obtained every 12 months for patients using diuretics, according to NCQA HEDIS guidelines.)
With time, the intervention group should have less medications for which laboratory test results are incomplete.
Therefore, the intervention group should have less medications with decision support reminders warning of incomplete laboratory test monitoring.
|
Laboratory tests during the previous 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 28, 2007
Primary Completion (Actual)
October 1, 2011
Study Completion (Actual)
October 1, 2011
Study Registration Dates
First Submitted
September 23, 2010
First Submitted That Met QC Criteria
September 23, 2010
First Posted (Estimate)
September 24, 2010
Study Record Updates
Last Update Posted (Estimate)
March 10, 2023
Last Update Submitted That Met QC Criteria
March 8, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 0710-59
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medication Histories in Outpatient Clinic Patients
-
Assiut UniversityNot yet recruitingGenetic Disease Clinical Presentation in Patients Attending Genetics Outpatient Clinic of Assiut University Children Hospital
-
University of AarhusAarhus University HospitalUnknownPatients in Highest Medication Error RiskDenmark
-
University of ChicagoCompletedTo Evaluate Clinical Outcomes, Safety, and Satisfaction of Patients Who Have Participated in a Same Day Outpatient Percutaneous Coronary Artery InterventionUnited States
-
University of ZurichDeep Breath Intelligence (DBI)RecruitingExhaled Breath Pattern After Medication Intake, in OSA Patients, or Other Pulmonary DiseasesSwitzerland
-
University Hospital, EssenFederal Ministry of Education and Reserach (BMBF)CompletedDetection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection. | Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors, | HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral...Germany
-
Dr Caeymaex LaurenceMinistry of Health, France; Paris 12 Val de Marne UniversityCompletedNosocomial Pneumonia | Extravasation Injury | Skin Lesion | Intubation Complication | Intensive Care Units, Neonatal | Misadventures to Patients During Surgical and Medical Care | Catheter-related Bloodstream Infection (CRBSI) Nos | Quality of Healthcare | Ventilator Adverse Event | Immature Newborn | Nasal... and other conditionsFrance
Clinical Trials on Medication History was printed
-
Cedars-Sinai Medical CenterNational Institutes of Health (NIH); National Institute on Aging (NIA)Completed
-
PictureRx, LLCUniversity of CincinnatiCompletedMedication ReconciliationUnited States
-
Vanderbilt UniversityActive, not recruitingMedication Adherence | Self EfficacyUnited States
-
Randers Regional HospitalAarhus University HospitalCompleted
-
The Cleveland ClinicCompletedMedication Reconciliation Between Patients' Self Report and Electronic Medical Record ListUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityCompletedHepatocellular Carcinoma | Survival | Hepatitis B Virus
-
First Affiliated Hospital Xi'an Jiaotong UniversityThe First Affiliated Hospital of Zhengzhou UniversityCompletedCOVID-19 | Organ Transplantation
-
South Tyneside and Sunderland NHS Foundation TrustNewcastle-upon-Tyne Hospitals NHS Trust; South Tees Hospitals NHS Foundation... and other collaboratorsCompletedObesity | Colorectal Cancer | Metabolic Syndrome | Colorectal Neoplasm | Colorectal Adenoma | Liver Fibrosis | Non-Alcoholic Fatty Liver DiseaseUnited Kingdom
-
Shandong UniversityUnknownHelicobacter Pylori InfectionChina
-
Seoul National University HospitalActive, not recruiting